Mehlen P, Llambi F
1Apoptosis, Cancer and Development Laboratory, Laboratoire labellisé 'La Ligue', CNRS FRE2870, Centre Léon Bérard, 28 rue Laennec, 69008 Lyon, France.
Br J Cancer. 2005 Jul 11;93(1):1-6. doi: 10.1038/sj.bjc.6602656.
Although cancer is a multifaceted disease, all cancer types share identical molecular and cellular mechanisms. These mechanisms involve a collection of alterations critical to the normal physiological functioning of cells, such as alterations of growth factor signalling pathways, angiogenesis, cell adhesion signals, DNA replication and apoptotic cell death. Many genes involved in the processes enumerated above are functionally inactive in tumour cells, designating them as putative 'tumour suppressor genes'. Back in the early 1990s, Vogelstein and colleagues suggested that a gene called DCC (for Deleted in Colorectal Cancer) could be a tumour suppressor gene because it was found to be deleted in more than 70% of colorectal cancers, as well as in many other cancers. During the last 15 years, controversial data have failed to firmly establish whether DCC is indeed a tumour suppressor gene. However, the recent observations that DCC triggers cell death and is a receptor for netrin-1, a molecule recently implicated in colorectal tumorigenesis, have prompted a renewal of interest in the role of DCC in tumorigenesis and suggest that the netrin-1/receptor pairs act as novel negative regulators of tumour development.
尽管癌症是一种多方面的疾病,但所有癌症类型都具有相同的分子和细胞机制。这些机制涉及一系列对细胞正常生理功能至关重要的改变,例如生长因子信号通路、血管生成、细胞粘附信号、DNA复制和凋亡性细胞死亡的改变。上述过程中涉及的许多基因在肿瘤细胞中功能失活,将它们指定为假定的“肿瘤抑制基因”。早在20世纪90年代初,沃格尔斯坦及其同事就提出,一种名为DCC(结直肠癌缺失基因)的基因可能是肿瘤抑制基因,因为在超过70%的结直肠癌以及许多其他癌症中都发现它缺失。在过去的15年里,有争议的数据未能确凿地证实DCC是否确实是肿瘤抑制基因。然而,最近的观察结果表明,DCC触发细胞死亡,并且是netrin-1的受体,netrin-1是一种最近与结直肠癌发生相关的分子,这促使人们重新关注DCC在肿瘤发生中的作用,并表明netrin-1/受体对作为肿瘤发展的新型负调节因子发挥作用。